Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_4022_Библиотеки_им_академика_М_И_Перельмана
.pdf
491
Литература
of-hospital placebo in hip arthroplasty patients. A double-blind, randomized
comparison // Arch. Intern. Med. — 2000. — Vol. 160. — P. 2208–2215.
Hull R.D., Raskob G.E., Brant R.F. et al. Low-molecular-weight heparin
vs heparin in the treatment of patients with pulmonary embolism // Arch.
Intern. Med. — 2000. — Vol. 160. — P. 229–236.
Hull R.D., Raskob G.E., Rosenbloom D. et al. Treatment of proximal vein
thrombosis with subcutaneous low-molecular-weight heparin vs intrave-
nous heparin: an economic perspective // Arch. Intern. Med. — 1997. —
Vol. 157. — P. 289–294.
Hyers T.M., Hull R., Morris T.A. et al. Antithrombotic therapy for venous
thrombolic disease // Chest. — 2001. — Vol. 119. — P. 176–193.
ICSI Health Care Guideline Antithrombotic Therapy Supplement. —
10
th
ed. — April, 2011. URL: http://www.icsi.org
ICSI Health Care Guideline Venous Thromboembolism Diagnosis and
Treatment. — 11
th
ed. — March, 2011. URL: http://www.icsi.org
ICSI Health Care Guideline Venous Thromboembolism Prophylaxis. —
8
th
ed. — September, 2011. URL: http://www.icsi.org
Imberti D., Prisco D. Retrievable vena cava filters: key considerations //
Thromb. Res. — 2008. — Vol. 122. — P. 442–449.
Jain M., Schmidt G.A. VTE: prevention and prophylaxis // Semin. Respir.
Crit. Care Med. — 1997. — Vol. 18. — P. 79–90.
James A.H., Jamison M.G., Brancazio L.R., Myers E.R. Venous thromboembo-
lism during pregnancy and the postpartum period: incidence, risk factors, and
mortality // Am. J. Obstet. Gynecol. — 2006. — Vol. 194. — P. 1311–1315.
Jick H., Kaye J.A., Vasilakis-Scaramozza C., Jick S.S. Risk of venous thrombo-
embolism among users of third generation oral contraceptives compared with
users of oral contraceptives with levonorgestrel before and after 1995: cohort
and case-control analysis // BMJ. — 2000. — Vol. 321. — P. 1190–1195.
Jilma B., Kamath S., Lip G.Y.H. Antithrombotic therapy in special circum-
stances pregnancy and cancer // BMJ. — 2003. — Vol. 326. — P. 37–40.
Jorgensen L.N., Wille-Jorgensen P., Hauch O. Prophylaxis of postoperative
thromboembolism with low molecular weight heparins // Br. J. Surg. —
1993. — Vol. 80. — P. 689–704.
Jorgensen P.S., Warming T., Hansen K. et al. Low molecular weight heparin
(Innohep) as thromboprophylaxis in outpatients with a plaster cast: a venogra-
fic controlled study // Thromb. Res. — 2002. — Vol. 105. — P. 477–480.
Jubelirer S.J. VTE and malignant brain tumors: a review // Clin. Appl.
Thromb. Hemostas. — 1996. — Vol. 2. — P. 130–136.
Kahn S.R., Solymoss S., Lamping D.L., Abenhaim L. Long-term outcomes
after deep vein thrombosis: postphlebitic syndrome and quality of life //
J. Gen. Intern. Med. — 2000. — June; 15 (6). — P. 425–429.
Kakar V.V., Boeckl O., Boneu B. et al. Eficacy and safety of a low molecular
weight heparin for prophylxis of postoperative venous thromboembolism. A Eu-
ropean multicenter trial // World. J. Surgery. — 1997. — Vol. 21. — P. 2–9.
270.
271.
272.
273.
274.
275.
276.
277.
278.
279.
280.
281.
282.
283.
284.
285.
492
Литература
Kakkar A.K., Kadziola Z., Williamson R.C.N. et al. Low molecular weight
heparin (LMWH) therapy and survival in advanced cancer // Blood. —
2002. — Vol. 100. — 148a.
Kakkar A.K., Williamson R.C.N. Prevention of VTE in cancer patients //
Semin. Thromb. Hemost. — 1999. — Vol. 25. — P. 239–243.
Kakzanov V., Monagle P., Chan A.K. Thromboembolism in infants and
children with gastrointestinal failure receiving long-term parenteral nutri-
tion // J. Parenter. Enteral. Nutr. — 2008. — Vol. 32. — P. 88–93.
Kalafatis M., Rand M.D., Mann K.G. The mechanism of inactivation of
human factor V and human factor Va by activated protein C // J. Biol.
Chem. — 1994. — Vol. 269. —P. 31869–31880.
Kamphuisen P.W., Eikenboom J.C., Rosendaal F.R. et al. High factor VIE
antigen levels increase the risk of venous thrombosis but are not associated
with polymorphisms in the von Willebrand factor and factor VIII gene //
Br. J. Haematol. — 2001. — Vol. 115. — P. 156–158.
Kapoor M., Kupfer Y.Y., Tessler S. Subcutaneous heparin prophylaxis sig-
nificantly reduces the incidence of venous thromboembolic events in the
critically ill // Crit. Care Med. — 1999. — Vol. 27 (Suppl.). — A69.
Kawamata T., Takeshita M., Kubo O. et al. Management of intracranial
hemorrhage associated with anticoagulant therapy // Surg. Neurol. —
1995. — Vol. 44. — P. 438–443.
Kearon C. Epidemiology of venous thromboembolism // Semin. Vasc.
Med. — 2001. — Vol. 1 (1). — P. 7–27.
Kearon C. Natural History of venous thromboembolism // Semin. Vasc.
Med. — 2001. — Vol. 1 (1). — P. 2–397.
Kearon C. Natural history of venous thromboembolism // Circulation. —
2003. — Vol. 107. — P. 122–130.
Kearon C., Gent M., Hirst J. et al. A comparison of three months of anticoagu-
lation with extended anticoagulation for a first episode of idiopathic venous
thromboembolism // New Engl. J. Med. — 1999. — Vol. 340. — P. 901–907.
Kearon C., Ginsberg J.S., Kovacs M.J. et al. Comparison of low-intensity
warfarin therapy with conventional-intensity warfarin therapy for long-
term prevention of recurrent venous thromboembolism // New Engl. J.
Med. — 2003. — Vol. 349. — P. 631–639.
Kemkes-Matthes B., Matthes K.J.M. Protein Z // Semin. Thromb. He-
most. — 2001. — Oct.; 27 (5). — P. 551–556.
Khamashta M.A., Hunt B.J. Moderate dose oral anticoagulant therapy in
patients with the antiphospholipid syndrome? No // J. Thromb. Hae-
most. — 2005. — Vol. 3.— P. 844–845.
Khan S., Dickerman J. Hereditary thrombophilia // Thromb. J. — 2006.
URL: http://www.4:154:15doi:10.1186/1477-9560-4-15.
Khorana A.A., Kuderer N.M., Culakova E. et al. Development and vali-
dation of a predictive model for chemotherapy-associated thrombosis //
Blood. — 2008. — Vol. 15. — P. 4902–4907.
286.
287.
288.
289.
290.
291.
292.
293.
294.
295.
296.
297.
298.
299.
300.
301.
493
Литература
Kleber F.X., Witt C., Vogel G. et al. Randomized Comparison of Enoxaparin
With Unfractionated Heparin for the Prevention of Venous Theomboem-
bolism in Medical Patients With Heart Failure or Severe Respiratory Dis-
ease // Am. Heart J. — 2003. — Vol. 145 (4). — P. 614–621.
Klepetko W., Mayer E., Sandoval J. et al. Interventional and surgical mo-
dalities of treatment for pulmonary arterial hypertension // J. Am. Coll.
Cardiol. — 2004. — Vol. 43 (12 Suppl. S). — 73S–80S.
Knight M. Antenatal pulmonary embolism: risk factors, management and
outcomes // BJOG. — 2008. — Vol. 115. — P. 453–461.
Knudson M.M., Morabito D., Paiement G.D. et al. Use of low molecu-
lar weight heparin in preventing thromboembolism in trauma patients //
J. Traum. — 1996. — Vol. 41. — P. 446–459.
Koch A., Ziegler S., Breitschwerdt H. et al. Low molecular weight heparin and
unfractionated heparin in thrombosis prophylaxis: meta-analysis based on
original patient data // Thromb. Res. — 2001. — Vol. 102. — P. 295–309.
Koch M.O., Smith J.A. Low molecular weight heparin and radical prostate-
ctomy: a prospective analysis of safety and side effects // Prostate Cancer
Prostatic Dis. — 1997. — Vol. 1. — P. 101–104.
Konstantinides S. Trombolysis in submassive pulmonary embolism? Yes //
J. Throm. Haem. — 2003. — Vol. 1 (6). — P. 1127–1130.
Konstantinides S., Geibel A., Heusel G. et al. Heparin plus alteplese com-
pared with heparin alone in patients with submassive pulmonary embo-
lism // New Engl. J. Med. — 2002. — Vol. 347. — P. 1143–1150.
Konstantinides S., Geibel A., Kasper W. et al. Patent foramen ovale is an
important predictor of adverse outcome in patients with major pulmonary
embolism // Circulation. — 1998. — Vol. 97. — P. 1946–1951.
Konstantinides S., Tiede N., Geibel A. et al. Comparison of alteplase versus
heparine for resolution of major pulmonary embolism // Am. J. Cardiol. —
1998. — Vol. 82. — P. 966–970.
Kroll M.H. Manual of coagulation disorders. — 2001. — P. 1–226.
Kruger S., Merx M.W., Graf J. Utility of brain natriuretic peptide to predict
right ventricular dysfunction and clinical outcome in patients with acute
pulmonary embolism // Circulation. — 2003. — Vol. 108. — e94–e95.
Kruip M.J., Leclercq M.G., Van der H.C. et al. Diagnostic strategies for
excluding pulmonary embolism in clinical outcome studies. A systematic
review // Ann. Intern. Med. — 2003. — Vol. 138. — P. 941–951.
Kucher N., Rossi E.,
De Rosa M., Goldhaber S.Z. Massive pulmonary em-
bolism
// Circulation. — 2006. — Vol. 113. — P. 577–582.
Kuipers S., Cannegieter S.C., Middeldorp S. et al. The absolute risk of ve-
nous thrombosis after air travel: a cohort study of 8755 employees of inter-
national organizations // PLoS Med. — 2007. — Vol. 4. — e290.
Kupfer Y., Anwar J., Senenviratne C. et al. Prophylaxis with subcutaneous
heparin significantly reduces the incidence of deep venous thrombophlebi-
tis in the critically ill // Am. J. Respir. Crit. Care Med. — 1999. — Vol. 159
(Suppl.). — A519.
302.
303.
304.
305.
306.
307.
308.
309.
310.
311.
312.
313.
314.
315.
316.
317.
494
Литература
Lane D.A., Bayston T., Olds R.J. et al. Antithrombin mutation database:
2
nd
(1997) update. For the Plasma Coagulation Inhibitors Subcommit-
tee of the Scientific and Standardization Committee of the International
Society on Thrombosis and Haemostasis // Thromb. Haemost. — 1997. —
Vol. 77. — P. 197.
Lane D.A., Grant P.J. Role of hemostatic gene polymorphisms in venous and
arterial thrombotic disease // Blood. — 2000. — Vol. 5. — P. 1517–1532.
Lane D.A., Mannucci P.M., Bauer K.A. et al. Inherited thrombophilia:
Part 1 // Thromb. Haemost. — 1996. — Vol. 76. — P. 651–662.
Lane D.A., Mannucci P.M., Bauer K.A. et al. Inherited thrombophilia:
Part 2 // Thromb. Haemost. — 1996. — Vol. 76. — P. 824–834.
Laporte S., Mismetti P., Decousus H., Uresandi F., Otero R., Lobo J.L. et al.
Clinical predictors for fatal pulmonary embolism in 15,520 patients with
venous thromboembolism: findings from the Registro Informatizado de
la Enfermedad TromboEmbolica venosa (RIETE) Registry // Circula-
tion. — 2008. — Vol. 117. — P. 1711–1716.
Lapostolle F., Surget V., Borron S.W. et al. Severe pulmonary embolism associa-
ted with air travel // New Engl. J. Med. — 2001. — Vol. 345. — P. 779–783.
Lassen M.R., Bauer K.A., Eriksson B.I., Turpie A.G.G. Postoperative fon-
daparinux versus preoperative enoxaparin for prevention of venous throm-
boembolism in elective hip-replacement surgery: a randomised double-blind
comparison // Lancet. — 2002. — Vol. 359. — P. 1715–1720.
Lassen M.R., Borris L.C., Jensen H.P. et al. Dose relation in the preven-
tion of proximal vein thrombosis with a low molecular weight heparin
(tinzaparin) in elective hip arthroplasty // Clin. Appl. Thromb. Hemo-
stas. — 2000. — Vol. 6. — P. 53–57.
Lassen M.R., Borris L.C., Kaltoft-Sorensen M. et al. Clinical limitations of
risk assessment models // Blood. Coagul. Fibrinolysis. — 1999. — Vol. 10
(Suppl. 2). — S45–S51.
Lassen M.R., Borris L.C., Nakov R.L. Use of the low-molecular-weight
heparin reviparin to prevent deep-vein thrombosis after leg injury requiring
immobilization // New Engl. J. Med. — 2002. — Vol. 347. — P. 726–730.
Lausen I., Jensen R., Jorgensen L.N. et al. Incidence and prevention of deep
venous thrombosis occurring late after general surgery: randomised con-
trolled study of prolonged thromboprophylaxis // Eur. J. Surg. — 1998. —
Vol. 164. — P. 657–663.
Le Gal G., Righini M., Parent F. Diagnosis and management of subsegmental
pulmonary embolism // J. Thromb. Haemost. — 2006. — Vol. 4. — P. 724–731.
Le Gal G., Righini M., Roy P.M. et al. Prediction of pulmonary embolism
in the emergency department: the revised Geneva score // Ann. Intern.
Med. — 2006. — Vol. 144. — P. 165–171.
Leclerc J.R., Gent M., Hirsh J. et al. The incidence of symptomatic VTE
during and after prophylaxis with enoxaparin: a multi-institutional cohort
318.
319.
320.
321.
322.
323.
324.
325.
326.
327.
328.
329.
330.
331.
495
Литература
study in patients who underwent hip or knee arthroplasty // Arch. Intern.
Med. — 1998. — Vol. 158. — P. 873–878.
Lee A., Agnelli G., Buller H. et al. Dose-response study of recombinant
factor VIIa/tissue factor inhibitor recombinant nematode anticoagulant
protein C2 in prevention of postoperative venous thromboembolism in
patients undergoing total knee replacement // Circulation. — 2001. —
Vol. 104. — P. 74–78.
Lee B.H., Park J.S., Park J.H. et al. The effect and safety of the Antithrom-
botic therapies in patients with atrial fibrillation and CHADS score 1 //
J. Cardiovasc. Electrophysiol. — 2010. — Vol. 21 (5). — P. 501–507.
Lemaitre R.N., Heckbert S.R., Psaty B.M. et al. Hormonale replacement
therapy and associated risk of stroke in postmenopausal women // Arch.
Intern. Ved. — 2002. — Vol. 162. — P. 1954–1960.
Lensing A.W., Hirsh J. Rationale and results of thrombolytic therapy for deep
vein thrombosis // In: Vascular. diagnosis / Ed. E.F. Bernstein. — 4
th
ed —
1994. — P. 875–879.
Lensing A.W.A., Doris C.I., McGrath F.P. et al. A comparison of com-
pression ultrasound with color Doppler ultrasound for the diagnosis of
symptomless postoperative deep vein thrombosis // Arch. Intern. Med. —
1997. — Vol. 157. — P. 765–768.
Levine M.N., Hirsh J., Gent M. et al. Optimal duration of oral anticoagu-
lant therapy: a randomized trial comparing four weeks with three months
of warfarin in patients with proximal deep vein thrombosis // Thromb.
Haemost. — 1995. — Vol. 74. — P. 606–611.
Levine M.N., Raskob G., Landefeld S. et al. Hemorrhagic complications of an-
ticoagulant treatment // Chest. — 2001. — Vol. 119 (Suppl.). — 108S–121S.
Lieberman J.R., Wollaeger J., Dorey F. et al. The efficacy of prophylaxis
with low-dose warfarin for prevention of pulmonary embolism following
total hip arthroplasty // J. Bone Joint Surg. Am. — 1997. — Vol. 79. —
P. 319–325.
Lilienfeld D.E., Chan E., Ehland J. et al. Mortality from pulmonary em-
bolism in the United States: 1962 to 1984 // Chest. — 1990. — Vol. 98. —
P. 1067–1072.
Lindahl T.L., Lundahl T.H., Nilsson L. et al. APC-resistance is a risk factor for
postoperative thromboembolism in elective replacement of the hip or knee —
a prospective study // Thromb. Haemost. —1999. — Vol. 81. — P. 18–21.
Lindblad B., Eriksson A., Bergqvist D. Autopsy-verified pulmonary embo-
lism in a surgical department: analysis of the period from 1951 to 1988 //
Br. J. Surg. — 1991. — Vol. 78. — P. 849–852.
Lindhoff-Last E., Kreutzenbeck H.-J., Magnani H.N. Treatment of 51 preg-
nancies with danaparoid because of heparin intolerance // Thromb. Hae-
most. — 2005. — Vol. 93. — P. 63–69.
Lindner D.J., Edwards J.M., Phinney E.S. et al. Long-term hemodynamic
and clinical sequelae of lower extremity deep vein thrombosis // J. Vasc.
Surg. — 1986. — Vol. 4. — P. 436–442.
332.
333.
334.
335.
336.
337.
338.
339.
340.
341.
342.
343.
344.
496
Литература
Link K.P. Discovery of Dicumarol and its sequels // Circulation. — 1959. —
Vol. 19. — P. 97.
Lo G.K., Juhl D., Warkerntin T.E., Sigouinc C.S. et al. Evaluation of pretest clini-
cal score (4 T’s) for the diagnosis of heparin-induced thrombocytopenia in
two clinical settings // J. Thromb. Haemost. — 2006. — Vol. 4. — P. 759–765.
Lohr J.M., Kerr T.M., Lutter K.S. et al. Ower extremity calf thrombosis, to
treat or not treat? // J. Vasc. Sur. — 1991. — Vol. 14. — P. 618–623.
Lu D., Kalafatis M., Mann K.G. et al. Comparison of activated protein
C/protein S — mediated inactivation of human factor VIII and factor V //
Blood. — 1996. — Vol. 87. — P. 4708–4717.
Lualdi J.C., Goldhaber S.Z. Right ventricular disfunction after acute pul-
monary embolism // Pathophysiologic factors, detection and therapeutic
implication // Am. Heart J. — 1995. — Vol. 130. — P. 1276–1282.
Macdonald R.L., Amidei C., Lin G. et al. Safety of perioperative subcuta-
neous heparin for prophylaxis of VTE in patients undergoing craniotomy //
Neurosurgery. — 1999. — Vol. 45. — P. 245–252.
Mannucci P.M. Thombosis and bleeding disorders outside Western coun-
tries // J. Thromb. Haemost. — 2007. — Vol. 5 (Suppl. 1). — S. 68–72.
Mant M.J., O’Brien B.D., Thong K.L. et al. Haemorrhagic complications of
heparin therapy // Lancet. — 1977. — Vol. 1. — P. 1133–1135.
Marchiori A., Verlato F., Sabbion P. et al. High versus low doses of unfrac-
tionated heparin for the treatment of superficial thrombophlebitis of the leg:
a prospective, controlled, randomized study // Haematologica. — 2002. —
Vol. 87. — P. 523–527.
Marinella M.A., Kathula S.K., Markert R.J. Spectrum of upper-extrem-
ity deep venous thrombosis in a community teaching hospital // Heart.
Lung. — 2000. — Vol. 29. — P. 113–117.
Mark A. Crowther M.D., Jeff S. Ginsberg et al. A comparison of two intensi-
ties of warfarin for the prevention of recurrent thrombosis in patients with
the antiphospholipid antibody syndrome // New Engl. J. Med. — 2003. —
Vol. 349 (12). — P. 1133–1138.
Mason A.R., McBurney P.G., Fuller M.P. et al. Successful use of fonda-
parinux as an alternative anticoagulant in a 2-month-old infant // Pediatr.
Blood. Cancer. — 2008. — Vol. 50. — P. 1084–1085.
Maxwell C.L., Myers E.R., Clarke-Pearson D.L.
Cost-effectiveness of deep
venous thrombosis prophylaxis in gynecologic oncology surgery
// Obstet.
Gynecol. — 2000. — Vol. 95. — P. 206–214.
McColl M.D., Ramsay J.E.,
Tait R.C. et al. Risk factors for pregnancy associ-
ated venous thromboembolism // Thromb. Haemost. — 1997. — Vol. 78. —
P. 1183–1188.
McKinley W.O., Jackson A.B., Cardenas D.D. et al. Long-term medical com-
p lications after traumatic spinal cord injury: a regional model systems ana-
lysis // Arch. Phys. Med. Rehabil. — 1999. — Vol. 80. — P. 1402–1410.
345.
346.
347.
348.
349.
350.
351.
352.
353.
354.
355.
356.
357.
358.
359.
497
Литература
McMurtry A.L., Owings J.T., Anderson J.T. et al. Increased use of prophylactic
vena cava filters in trauma patients failed to decrease overall incidence of pul-
monary embolism // J. Am. Coll. Surg. — 1999. — Vol. 189. — P. 314–320.
Meissner M.H. Deep venous thrombosis in the trauma patient // Semin.
Vasc. Surg. — 1998. — Vol. 11. — P. 274–282.
Meneveau N., Seronde M.F., Blonde M.C. et al. Management of unsuccess-
ful thrombolysis in acute massive pulmonary embolism // Chest. — 2006. —
Vol. 129. — P. 1043–1050.
Mewissen M.W., Seabrook G.R., Meissner M.H. et al. Catheter-directed
thrombolysis for lower extremity deep venous thrombosis: report of a na-
tional multicenter registry // Radiology. — 1999. — Vol. 211. — P. 39–49.
Meyer C.S., Blebea J., Davis K. et al. Surveillance venous scans for deep ve-
nous thrombosis in multiple trauma patients // Ann. Vasc. Surg. — 1995. —
Vol. 9. — P. 109–114.
Miller G.A., Sutton G.C., Kerr I.H. Comparison of streptokinase and
heparin in treatment of isolated acute massive pulmonary embolism //
Br. Heart. J. — 1971. — Vol. 33. — P. 616.
Million women study collaborators. Patterns of use hormonal replacement
therapy in one million women in Britain, 1996–2000 // BJOG. — 2002. —
Vol. 109. — P. 1319–1330.
Misita C.P., Moll S. Antiphospholipid antibodies circulation. — 2005. —
Vol. 112. — e39–e44.
Mismetti P., Laporte-Simitsidis S., Tardy B. et al. Prevention of VTE in
internal medicine with unfractionated or low-molecular-weight heparins:
a meta-analysis of randomised clinical trials // Thromb. Haemost. —
2000. — Vol. 83. — P. 14–19.
Mismetti P., Rivron-Guillot K., Quenet S. et al. A prospective long-term study
of 220 patients with a retrievable vena cava filters for secondary prevention
of venous thromboembolism // Chest. — 2007. — Vol. 131. — P. 223–229.
Mo M., Kapelanski D.P., Mitruka S.N. et al. Reoperative pulmonary thrombo-
endarterectomy // Ann. Thorac. Surg. — 1999. — Vol. 68. — P. 1770–1776.
Monreal M., Alastrue A., Rull M. et al. Upper extremity deep vein throm-
bosis in cancer patients with venous access devices — prophylaxis with a
low molecular weight heparin (Fragmin) // Thromb. Haemost. — 1996. —
Vol. 75. — P. 251–253.
Montgomery K.D., Geerts W.H., Potter H.G. et al. Practical management
of VTE following pelvic fractures // Orthop. Clin. North Am. — 1997. —
Vol. 28. — P. 397–404.
Morris G.K. Prevention of VTE: a survey of methods used by orthopaedic
and general surgeons // Lancet. — 1980. — Vol. 2. — P.
572–574.
Napolitano L.M., Garlapati V.S., Heard S.O. et al. Asymptomatic deep ve-
nous thrombosis in the trauma patient: is an aggressive screening protocol
justified?
// J. Trauma. — 1995. — Vol. 39. — P. 651–659.
360.
361.
362.
363.
364.
365.
366.
367.
368.
369.
370.
371.
372.
373.
374.
498
Литература
Nesheim M.E., Nichols W.L., Cole T.L. et al. Isolation and study of an ac-
quired inhibitor of human coagulation factor V // J. Clin. Invest. — 1986. —
Vol. 77. — P. 405–415.
Neudecker J., Sauerland S., Neugebauer E. et al. The European Associa-
tion for Endoscopic Surgery clinical practice guideline on the pneumoperi-
toneum for laparoscopic surgery // Surg. Endosc. — 2002. — Vol. 16. —
P. 1121–1143.
Newall F., Barnes C., Savoia H. et al. Warfarin therapy in children who
require long-term total parenteral nutrition // Paediatrics. — 2003. —
Vol. 112. — e386–e388.
Nicolaides A.N., Bergqvist D., Hull R. et al. Prevention of VTE: interna-
tional consensus statement (guidelines according to scientific evidence) //
Int. Angiol. — 1997. — P. 163–168.
Nordstrom M., Lindblad B. Autopsy-verified venous thromboembolism with-
in a defined urban population — the city of Malmo, Sweden // APMIS. —
1998. — Vol. 106. — P. 378–384.
Oda T., Fuji T., Kato Y. et al. Deep venous thrombosis after posterior spinal
surgery // Spine. — 2000. — Vol. 25. — P. 2962–2967.
Oger E. Incidence of venous thromboembolism: a community-based study
in Western France. EPI-GETBP Study Group. Groupe d’Etude de la
Thrombose de Bretagne Occidentale // Thromb. Haemost. — 2000. —
Vol. 83. — P. 657–660.
Ouriel K., Gray B., Clair D.G. et al. Complications associated with the use
of urokinase and recombinant tissue plasminogen activator for catheter-
directed peripheral arterial and venous thrombolysis // J. Vasc. Interv.
Radiol. — 2000. — Vol. 11. — P. 295–298.
Palareti G., Cosmi B., Legnani C. et al. D-dimer testing to determine
the duration of anticoagulation therapy // New Engl. J. Med. — 2006. —
Vol. 355. — P. 1780–1789.
Partsch H. Therapy of deep vein thrombosis with low molecular weight hepa-
rin, leg compression and immediate ambulation // Vasa. — 2001. — Vol. 30. —
P. 195–204.
Partsch H., Blattler W. Compression and walking versus bed rest in the
treatment of proximal deep venous thrombosis with low molecular weight
heparin // J. Vasc. Surg. — 2000. — Vol. 32. — P. 861–869.
Passman M.A., Farber M.A., Marston W.A. et al. Prospective screening for
postoperative deep venous thrombosis in patients undergoing infrainguinal
revascularization // J. Vasc. Surg. — 2000. — Vol. 32. — P. 669–675.
Pendleton R., Wheeler M.M., Rodgers G.M. Argatroban dosing of patients
with heparin-induced thrombocytopenia and an elevated aPTT due to
antiphospholipid antibody syndrome // Ann. Pharmacother. — 2006. —
May; 40 (5). — P. 972–976.
Pengo V., Lensing A.W., Prins M.H. et al. Incidence of chronic thromboem-
bolic pulmonary hypertension after pulmonary embolism
// New Engl. J.
Med. — 2004. — Vol. 350. — P. 2257–2264.
375.
376.
377.
378.
379.
380.
381.
382.
383.
384.
385.
386.
387.
388.
499
Литература
Perrier A., Bounameaux H. Cost-effective diagnosis of deep vein thrombo-
sis and pulmonary embolism // Thromb. Haemost. — 2001. — Vol. 86. —
P. 475–487.
Perrier A., Miron M.J., Desmarais S.D. et al. Using clinical evaluation and
lung scan to rule out suspected pulmonary embolism: Is it a valid option in
patients with normal results of lower-limb venous compression ultrasonog-
raphy? // Arch. Intern. Med. — 2000. — Vol. 160. — P. 512–516.
Perrier A., Roy P.M., Sanchez O. et al. Multidetector-row computed tom-
ography in suspected pulmonary embolism // New Engl. J. Med. — 2005. —
Vol. 352. — P. 1760–1768.
Pieralli F., Olivotto I., Vanni S. et al. Usefulness of bedside testing for brain
natriuretic peptide to identify right ventricular dysfunction and outcome
in normotensive patients with acute pulmonary embolism / /Am. J. Car-
diol. — 2006. — Vol. 97. — P. 1386–1390.
Planes A., Samama M.M., Lensing A.W.A. et al. Prevention of deep vein
thrombosis after hip replacement; comparison between two low-molecu-
lar-weight heparins, tinzaparin and enoxaparin // Thromb. Haemost. —
1999. — Vol. 81. — P. 22–25.
Planes A., Vochelle N., Darmon J.-Y. et al. Risk of deep-venous thrombosis
after hospital discharge in patients having undergone total hip replacement:
double-blind randomised comparison of enoxaparin versus placebo // Lan-
cet. — 1996. — Vol. 348. — P. 224–228.
Pomp E.R., Le Cessie S., Rosendaal F.R., Doggen C.J. Risk of venous throm-
bosis: obesity and its joint effect with oral contraceptive use and prothrom-
botic mutations // Br. J. Haematol. — 2007. — Vol. 139. — P. 289–296.
Pomp E.R., Lenselink A.M., Rosendaal F.R., Doggen C.J. Pregnancy, the post-
partum period and prothrom-botic defects: risk of venous thrombosis in the
MEGA study // J. Thromb. Haemost. — 2008. — Vol. 6. — P. 632–637.
Pomp E.R., Rosendaal F.R., Doggen C.J. Alcohol consumption is associ-
ated with a decreased risk of venous thrombosis // Thromb. Haemost. —
2008. — Vol. 99. — P. 59–63.
Pomp E.R., Rosendaal F.R., Doggen C.J. Smoking increases the risk of ve-
nous thrombosis and acts synergistically with oral contraceptive use // Am.
J. Hematol. — 2008. — Vol. 83. — P. 97–102.
Powell M., Kirshblum S.,
O’Connor K.C. Duplex ultrasound screening for
deep vein thrombosis in spinal cord injured patients at rehabilitation admis-
sion // Arch. Phys. Med. Rehabil. — 1999. —
Vol. 80. — P. 1044–1046.
Prandoni P. Below-knee compression stockings for prevention of the post-
thrombotic syndrome: a randomized study [abstract]
// Pathophysiol.Hae-
most. Thromb. — 2002. — Vol. 32 (Suppl. 2). — S. 72.
Prandoni P. Heparins and venous thromboembolism: current practice and
future directions // Thrombosis and Haemostasis. — 2001. — Vol. 86. —
P. 499–508.
389.
390.
391.
392.
393.
394.
395.
396.
397.
398.
399.
400.
401.
500
Литература
Prandoni P., Bernardi E., Tormene D. et al. Diagnosis of recurrent deep vein
thrombosis // Semin. Vasc. Med. — 2001. — Vol. 1 (1). — P. 55–60.
Prandoni P., Sabbion P., Tanduo C. et al. Prevention of venous throm-
boembolism in high-risk surgical and medical patients // Semin. Vasc.
Med. — 2001. — Vol. 1 (1). — P. 61–70.
Pritchard K.I., Paterson A.H.G., Paul N.A. et al. Increased thromboembolic
complications with concurrent tamoxifen and chemotherapy in a rando-
mized trial of adjuvant therapy for women with breast cancer // J. Clin.
Onol. — 1996. — Vol. 14. — P. 2731–2737.
Pruszczyk P., Kostrubiec M., Bochowicz A. et al. N-terminal pro-brain
natriuretic peptide in patients with acute pulmonary embolism // Eur.
Respir. J. — 2003. — Vol. 22. — P. 649–653.
Rand M.D., Kalafatis M., Mann K.G. Platelet coagulation factor Va: The
major secretary platelet phosphoprotein // Blood. — 1994. — Vol. 83. —
P. 2180–2190.
Rathbun S.W., Raskob G.E., Whitsett T.L. Sensitivity and specificity of heli-
cal computed tomography in the diagnosis of pulmonary embolism: a sys-
tematic review // Ann. Intern. Med. — 2000. — Vol. 132. — P. 227–232.
RCOG Reducing the risk of thrombosis and embolism during pregnancy and
the puerperium // Green-top guideline. — 2009. — Vol. 37. — P. 1–35.
Reitsma P.H., Bernardi F., Doig R.G. et al. Protein C deficiency: A database of
mutations, 1995 update // Thromb. Haemost. — 1995. — Vol. 73. — P. 876.
Ribeiro A., Juhlin-dannfelt A., Johnsson H. et al. Echocardiography dopler
in pulmonary embolism right ventricular dysfunction as a predictor of mor-
tality rate // Am. Heart J. — 1997. — Vol. 134. — P. 479–487.
Ribeiro A., Lindmarker P., Johnasson H. et al. Pulmonary embolism: one-
year follow-up with Echocardiography Doppler and five year survival
analysis // Circulation. — 1999. — Vol. 99. — P. 1325–1330.
Ridker P.M. Long-term low-dose warfarin use is effective in the prevention
of recurrent venous thromboembolism: yes // Thromb. Haemost. — 2004. —
Vol. 2. — P. 1034–1037.
Ridker P.M., Goldhaber S.Z., Danielson E. et al. Long-term, low-intensity
warfarin therapy for the prevention of recurrent venous thromboembo-
lism // New Engl. J. Med. — 2003. — Vol. 348. — P. 1425–1434.
Robertson L., Langhorme W.O. et al. The Thrombosis Risk and Economic
Assessment of Thrombophilia Screening (Treats) Study. Thrombophilia in
pregnancy: a systematic review
// Br. J. Haematol. — 2005. — Vol. 132. —
P. 171–196.
Robinson K.S., Anderson D.R., Gross M. et al. Ultrasonographic screening
before hospital discharge for deep venous thrombosis after arthroplasty: the
Post-Arthroplasty Screening Study: a randomized, controlled trial // Ann.
Intern. Med. — 1997. — Vol. 127. — P. 439–445.
Rocha E., Martinez-Gonzalez M.A., Monies R. et al. Do the low molecu-
lar weight heparins improve efficacy and safety of the treatment of deep
402.
403.
404.
405.
406.
407.
408.
409.
410.
411.
412.
413.
414.
415.
416.
Соседние файлы в папке Библиотека им академика М.И. Перельмана